Clinical and economic outcomes associated with intravenous albumin fluid use in the intensive care unit: a retrospective cohort study.

Shoroq M AltawalbehEman M AlmestarihiRawand A KhasawnehSuleiman Mohammad MomanyMera A AbabnehMohammad S Shawaqfeh

Published in: Expert review of pharmacoeconomics & outcomes research (2023)

IV Albumin use in the ICU was not associated with significant improvement in clinical outcomes, but with a remarkable increase in economic burden. The majority of patients received albumin for non-FDA-approved indications.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
intensive care unit
peritoneal dialysis
prognostic factors
skeletal muscle
weight loss